Showing all 1 result

  • Sort by:
  • $60

    Sativex (nabiximols) is the first cannabis-based medicine to be licensed in the UK. The drug can prescribed for the treatment for MS-related spasticity when a person has shown inadequate response to other symptomatic treatments or found their side effects intolerable. Sativex can be used in addition to a person’s current anti-spasticity medication.

    Prior to gaining a licence for use in MS-related spasticity, Sativex had been studied for its effects on a number of MS related symptoms including: spasticity and spasms, pain, bladder symptoms, tremor, and sleep disturbance.

    AVAILABILITY: In stock

No products were found matching your selection.

Navigation
Viewed

Recently Viewed

Close

Quickview

Close

Categories

My Cart

Close

Wishlist

Close
error: Content is protected !!